United Kingdom precision
medicine market is expected to register robust growth in the forecast period,
2023-2027. Precision
medicine evaluates the genes and proteins which are present in the body of a
patient to design the personalized treatment drug to cure the specific disease.
With such discoveries including single nucleotide polymorphism and microarray/
biochips in the field of precision medicine, the market is projected to
experience a boom in the upcoming years. Continuous research activities on
human genome are the future of precision medicine and has a potential to upend
the medical treatment on individual patients by understanding their genetics,
molecular profiles, and clinical characteristics. The growing prevalence of
cancer is further escalating the demand for precision medicine for personalized
therapeutics and diagnostics which is positively influence the growth of the
market.
Growing Prevalence of CNS Disorders is
Projected to Augment the Market Growth
CNS ailments include Alzheimer’s
disease, multiple sclerosis, epilepsy, afflict millions of individuals across
the globe which is primarily driving the market growth. Dementia affects more
than 50 million individuals worldwide. Alzheimer's disease, the most common
kind of dementia, accounts for 60-70 percent of all cases. The growth of the
industry is aided by an enhancing focus on targeted therapeutics and the
development of individualized medical treatment regimens for persons suffering
from CNS illnesses.
Elevating Prevalence of Cancer Across
the United Kingdom Drives the Market Growth
The escalating demand for precision
medicine methods across the developed countries like UK owing to the rising
prevalence of cancer and the increasing number of treatment candidates in
clinical trials. This, turn, is driving the market growth. In addition to this,
the rising number of cases of genetic diseases will continue to influence
positively the growth of precision medicine market. With this, the elevating
levels of urbanization and inflating level of disposable income are
accelerating the growth of the precision medicine market. The growing
expenditure on healthcare infrastructure and expanding geriatric population are
the major market drivers that support the growth of precision medicine market.
The recent development in technologies including the ultra-high throughout
sequencing and next-generation sequencing is expected to fuel the growth of the
market over the future years.
Extensive R&D Activities is
Anticipated to Bolster the Market Growth
The growing number of research and
development activities offer lucrative opportunities for the precision medicine
market growth. The enhancing focus of manufacturers on the adoption of upgraded
technologies and rise in the number of emerging economies will opportunities
for the precision medicine market growth in the upcoming years.
Download Sample Report
Market Segmentation
The United Kingdom precision medicine
devices market is segmented into products and services,
technology, application, end-user, regional distribution, and
competitive landscape. Based on product and services, the market is segmented
into precision medicine platforms, precision medicine tools, precision medicine
services. Based on technology, the
market is segmented into big data analytics, artificial intelligence,
bioinformatics, whole genome sequencing, companion diagnostics, next generation
sequencing (NGS), others). Based on application, the market is categorized into
oncology, immunology, cardiology, neurology, respiratory, others. Based on end
user, the market is divided into pharmaceutical and biotechnology companies,
healthcare IT, diagnostic companies, clinical research organization, research
institutes. To analyze
the market based on the region, the United Kingdom precision medicine devices
market is studied in major regions namely London, Southeast, East Anglia,
Scotland, Southwest, East Midlands, and Yorkshire & Humberside.
Market Players
Thermo Fischer Scientific United Kingdom, Qiagen
Manchester Limited, Illumina Cambridge Limited, Quest Diagnostic Limited,
Agilent Technologies UK Limited, GlaxoSmithKline Plc., Roche Diagnostics
Limited are the significant market players
operating in United Kingdom precision medicine devices market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered
|
·
Product and Services
·
Technology
·
Application
·
End Use
|
|
Regional scope
|
London, Southeast, East Anglia, Scotland,
Southwest, East Midlands, and Yorkshire & Humberside
|
|
Key companies profiled
|
Thermo Fischer Scientific United Kingdom, Qiagen Manchester
Limited, Illumina Cambridge Limited, Quest Diagnostic Limited, Agilent
Technologies UK Limited, GlaxoSmithKline Plc., Roche Diagnostics Limited
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to regional
& segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and
Excel through Email (We can also provide the editable version of the report
in PPT/Word format on special request)
|
Report Scope:
In this report, United Kingdom precision
medicine devices market has been segmented into following categories, in
addition to the industry trends which have also been detailed below:
·
United Kingdom Precision Medicine Devices
Market, By Product and Services:
o Precision Medicine Platforms
o Precision Medicine Tools
o Precision Medicine Services
·
United Kingdom Precision
Medicine Devices Market, By Technology:
o Big Data Analytics
o Artificial Intelligence
o Bioinformatics
o Whole Genome Sequencing
o Companion Diagnostics
o Next Generation Sequencing (NGS)
o Others
·
United Kingdom Precision
Medicine Devices Market, By Application:
o Oncology
o Immunology
o Cardiology
o Neurology
o Respiratory
o Others
·
United Kingdom Precision
Medicine Devices Market, By End User:
o Pharmaceutical and Biotechnology
Companies
o Healthcare IT
o Diagnostic Companies
o Clinical Research Organization
o Research Institutes
·
United Kingdom Precision
Medicine Devices Market, By Region:
o
London
o
Southeast
o
East
Anglia
o
Scotland
o
Southwest
o
East
Midlands
o
Yorkshire
& Humberside
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in United Kingdom precision medicine
devices market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
Detailed analysis and
profiling of additional market players (up to five).